Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 23, 2026TechnologiesOpen Access

Machine Learning in Personalized Medication Regimen Design for the Geriatric Population: Integrating Pharmacokinetic and Pharmacodynamic Modeling with Clinical Decision-Making

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAhmad R. AlsayedMAMohanad Al-DarrajiApplied Science Private UniversityMAMohannad Al-QaiseiahAl-Zaytoonah University of Jordan

Discussion

Loading...

Member takes

Implication

This review examines integrating machine learning with pharmacokinetic and pharmacodynamic modeling to enhance medication dosing accuracy in the geriatric population, suggesting improved clinical...

Key Points

  • The central aim is to explore how machine learning can enhance personalized medication regimens for older adults by improving pharmacokinetic and pharmacodynamic models.
  • Reviewed integration of machine learning techniques with pharmacokinetic and pharmacodynamic models.
  • Evaluated methods like Random Forest and XGBoost for accuracy in dosing predictions.
  • Discussed the importance of explainability tools and FAIR data principles for trust in models.
  • Machine learning models demonstrated superior predictive accuracy compared to conventional methods.
  • Random Forest and XGBoost provided more efficient computational workflows with better exposure predictions.
  • Concerns regarding algorithmic bias and the need for transparency in model outputs were highlighted.

Cite This Study

Alsayed et al. (2026) studied this question.

synapsesocial.com/papers/69e9bb6285696592c86ed1a3https://doi.org/10.3390/technologies14040241
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Scalable and accurate deep learning with electronic health records2018 · 2,663 citations
  2. 2External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients2022 · 25 citations
  3. 3The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure2011 · 380 citations
  4. 4Aging, Cellular Senescence, and Progressive Multiple Sclerosis2020 · 80 citations
  5. 5From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics2021 · 317 citations